Header Ads

Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial

August 03, 2020 ,
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...

from NDTV News - India-news https://ift.tt/2XmSgN8

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.